Aldeyra Therapeutics, Inc. (ALDX)
1.22
-0.13
(-9.63%)
USD |
NASDAQ |
Sep 24, 16:00
1.29
+0.07
(+5.74%)
After-Hours: 06:16
Aldeyra Therapeutics Gross Profit (Annual) : -0.252M for Dec. 31, 2025
Gross Profit (Annual) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Gross Profit (Annual) Data
| Date | Value |
|---|---|
| December 31, 2025 | -0.252M |
| December 31, 2024 | -0.2496M |
| December 31, 2023 | -0.2628M |
| December 31, 2022 | -0.2587M |
| December 31, 2021 | -0.2642M |
| December 31, 2020 | -0.0562M |
| December 31, 2019 | -0.0963M |
| December 31, 2018 | -0.071M |
| Date | Value |
|---|---|
| December 31, 2017 | -0.0378M |
| December 31, 2016 | -0.0358M |
| December 31, 2015 | -0.0188M |
| December 31, 2014 | -0.0011M |
| December 31, 2013 | 0.00 |
| December 31, 2012 | -0.0037M |
| December 31, 2011 | -0.0016M |
Gross Profit Definition
Annual, Interim and Preliminary Items - Commercial, Other Financial Companies
Gross Profit (Annual) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Gross Profit (Annual) Benchmarks
| Arrowhead Pharmaceuticals, Inc. | 805.52M |
| Oncolytics Biotech, Inc. | -0.07M |
| Sangamo Therapeutics, Inc. | 31.95M |
| Sarepta Therapeutics, Inc. | 1.314B |
| Anixa Biosciences, Inc. | -0.036M |